19
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Large Intravenous Loads of Bilirubin Photoconversion Products, in Contrast to Bilirubin, Do Not Cause Cholestasis in Bile Acid-Depleted Pigs

, , , &
Pages 246-253 | Received 14 Aug 1996, Accepted 08 Nov 1996, Published online: 08 Jul 2009
 

Abstract

Background: Large intravenous bilirubin infusions in bile acid-depicted pigs (BADF) destroy hepatocyte canalicular membrane microvilli (CMV) and cause cholestasis. This study examines whether bilirubin photoconversion product infusions do the same. Methods: The effects of systemic infusion of 135 µmol - kg−1 body weight bilirubin photoconversion products on CMV density and cholcretic response to intruportal bile acid infusion were studied in BADP. Furthermore, the effects of 135 µmol - kg−1 b.w. bilirubin infusion, cither through an artcriovenous bilirubin photoconversion shunt device (PCD) or intravenously, were measured in PCD-connected BADP. Results: Intravenous bilirubin photoconversion product infusions affected neither the CMV density nor the choleretic response to cholic acid infusion, and neither did bilirubin infusion through the PCD. In contrast, intravenous bilirubin infusion caused canalicular injury and cholestasis in four of six PCD-connected 13ADP. Conclusion: Bilirubin photo-conversion products do not destroy CMV or cause cholestasis in BADP. A bilirubin photoconversion shunt device can confer cholestasis protection to bilirubin-loaded BADP.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.